Form D · Biotechnology

Mira Dx, Inc.

Westport, CT · CIK 0001471338

Offering snapshot reported Aug 24, 2010 · SEC filing

Reported sold
$4.16M
Indefinite offering
Investors reported
52
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 1, 2009
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.08M$4.16MSep 14, 2009: $2,088,459.00Sep 14, 2009Aug 24, 2010: $4,158,459.00Aug 24, 2010

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$2,088,459 → $4,158,459
  • Reported investors30 → 52

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 24, 2010Amendment$4,158,459$2,070,000vs Sep 14, 200952SEC filing
Sep 14, 2009Initial$2,088,459No comparison30SEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-134400

Source: Form D, filed Aug 24, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Barbara Mignogna Korus Director, Executive
Stephen Miller Director, Executive
Mary Lake Polan Director
Andrew Weidhaas Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
292 North Avenue
Westport, CT, 06880